New JAMA feature gives writers some room for debate

Howard Bauchner
Howard Bauchner

Journals routinely provide fodder for debates on medical topics, but rarely offer a forum in which to hold those debates.

Enter JAMA's Viewpoint feature, in which the editor chooses a topic, picks a panel of experts and pits them against each another in print. The publication schedule is sporadic—Editor-in-Chief Howard Bauchner told MM&M he hopes to run four or five in a year and build up to one every month—but the response has been consistent. Bauchner said a March Viewpoint about slashing medical training time triggered a flurry of reader responses that has dwarfed any other published items since he took the reins in 2011.

Responses have gone beyond the scope of the medical discussion, signaling that the 129-year-old publication has tapped into something important.

“I've received about 10 ideas for future dueling viewpoints, so I'm always pleased when people feel engaged with what we're doing,” he said.

Bauchner said the column is part of a strategy to make his publication a more immersive experience. Other components of that plan include rolling out a new website and apps.

“Journals, if they sit on people's desks unread, are not very successful,” he said. “Journals have to engage their readers. That's true in print. And it's true on the web.”

But he says there are limits: “There's been a lot of questions that have arisen round Twitter and Facebook and blogging … I'm not certain 140 characters does the content justice, so although we have a presence in the social network arena, I don't know what our future will be there.”
You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.